The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.
Visualising Psychotropic Medicine (VPM)Presenting what can be a complex set of data in a useful and engaging way
Online CPD ResourceRCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Fundamentals of Clinical PsychopharmacologyBuy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
The Ten Secrets of Success in ScienceView Professor Trevor Robbins presenting his top tips
Neuroscience-based Nomenclature (NbN) for JoPJournal of Psychopharmacology chosen to trial new NbN
Fundamentals Wins BMA AwardFundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Not all in the mind – the contribution of brain science to modern psychiatryWatch Prof David Nutt's lecture in Manchester on YouTube
Benefits of BAP membership include:
- FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
- Reduced registration fees for the annual Summer Meeting.
- Half price subscription to the Online CPD Resource.
- Eligibility for prizes and awards.
- Student bursaries for the BAP Summer Meeting and international conferences.
- Reduced registration fees for selected partner association events.
- 50% OFF Royal Society of Biology membership (Read more)
- BAP Newsletter.
- Voting for BAP Officers and Council (full members only).
- Being part of one of the largest national psychopharmacology associations in the world.
|7th September 2019||32nd ECNP Congress||Copenhagen|
|10th September 2019||IoPPN 19th Maudlsey Forum 2019||King’s College London|
|12th September 2019||Drug Treatments in Affective Disorders||The International Centre for Life (Conferences), Newcastle upon Tyne|
Psychopharmacology Awards – Winners’ Short Orals
By Alexandra Pike
Posted on 19th July 2019
This session, in which winners of the Psychopharmacology Awards present their work, always has high attendance and this year was no exception. Dr Tom Freeman, the winner of the junior non-clinical award, presented on the role of cannabinoids in the development and treatment of addiction. He noted that recent policy changes in the UK have […]
Symposium 7 – What do computational models tell us about cognition in depression and psychosis?
By Ellie Smith
Posted on 19th July 2019
This symposium discussed how computational models could be used to explore decision-making and prediction learning in psychiatric disorders. By including computational modelling in our analyses we can identify and quantify key parameters, which are not visible to traditional analyses, and can often be successfully linked to the function of underlying neural systems or to clinically […]
Symposium 5 – From neuro-receptor binding to brain function: translational value of multimodal approaches in psychopharmacology
By Bronagh McCoy
Posted on 19th July 2019
Many techniques are currently available to look at systems-level function in the brain, but all have their limitations. For example, PET provides a precise measure around a specific receptor of interest, however, there are many receptors for which we don’t have ligands that bind to them. Many drugs also have multiple targets and may be […]
Psychedelics, addiction, and mental health
David talks to ABC Radio National about psychedelics, addiction, and mental health
24th February 2019
Hollywood past saves climber Hamish MacInnes from dementia death sentence
Stephen was quoted in the Times article about how Hamish MacInnes recovered from Dementia with the help of his films and books
22nd February 2019
BBC Radio 5 Live Drive Time - Alcohol Hangover
Chris Alford was talking with Anna and Chloe on BBC Radio 5 Live Drive Time about alcohol hangovers following the recent publication of a study showing that whether beer or wine was drunk first had no effect on the resulting hangover.
8th February 2019
Film and Mental Illness
Stephen Lawrie talks about the portrayal of mental illnesses on film
21st January 2019
MDMA Increases Cooperation and Recruitment of Social Brain Areas When Playing Trustworthy Players in an Iterated Prisoner's Dilemma
Mitul and his team found that participants on MDMA were more willing to cooperate than those given the placebo. Covered by: Live Science, Wired, Vice (German), IFL Science, CTV News.
9th January 2019
|Street Drugs Conference Wales 2019: Is the Dragon Still Smoking? |
13th July 2019
Overview of the latest Street Drugs Conference in Wales on 25th June.
Read the review
|REF2021 Success |
4th February 2019
Prof Allan Young, Prof Jeremy Hall and Prof Helen Cassaday selected to join REF2021 panel 4: Psychology, Psychiatry and Neuroscience
|Professor David Nutt Wins Academic Honorary Award in Istanbul |
9th November 2018
Professor David Nutt has won the Academic Honorary Award at the International Crime and Punishment Film Festival in Istanbul
|Mental health in young people - Press Briefing |
24th July 2018
Press coverage of the successful press briefing on 20th July on the importance of early intervention in mental illness in young people.
Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.